Wavegate, founded with a mission to revolutionize medical technology, focuses on developing innovative solutions in neuromodulation. The company's core vision is to provide advanced treatments for chronic pain through its proprietary Spinal Cord Stimulation (SCS) technology. Their flagship product, the Ellipse TM Spinal Cord Stimulator Platform, leverages StimuLux TM Active Loop TM technology to offer effective pain relief for patients who have not found success with medications, physical therapy, or surgery.
Wavegate has garnered attention from notable figures in the medical technology field and has attracted significant investment to support its groundbreaking research and development. The company has achieved key milestones in advancing SCS technology, positioning itself as a leader in the treatment of chronic pain. Through its innovative products, Wavegate has made a substantial impact on improving the quality of life for patients suffering from debilitating pain conditions.
